TriAltus Bioscience
Tom Round is an experienced sales and business development professional with a robust background in the biotechnology and life sciences sectors. Currently serving as the Director of Sales at Quantimetrix since February 2023, Tom previously held positions including Vice President of Business Development at TriAltus from June 2021 to January 2023, and Vice President of Commercial at Phase from February 2020 to November 2020. Tom's extensive experience also includes a lengthy tenure at Silver Lake Research Corporation, where responsibilities included Vice President of Sales & Business Development from April 1998 to January 2020.
This person is not in any teams
This person is not in any offices
TriAltus Bioscience
TriAltus develops innovative tools for the production and purification of genetically-engineered proteins. Their novel affinity tag system delivers proteins with ultra-high purity and yield in a single step. Having proven the CLīM technology on some extremely difficult proteins, TriAltus is now developing R&D partnerships to use CLīM to purify proteins for customer-defined projects.